
SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
latest_posts
- 1
'We are ready': NASA still on track to launch Artemis 2 astronauts to the moon April 1 - 2
Google's proposed data center in orbit will face issues with space debris in an already crowded orbit - 3
EU top diplomat Kallas arrives in Kiev to commemorate Bucha massacre - 4
Two IDF officers, civilian face indictment in alleged Gaza aid-truck smuggling scheme - 5
Ober Gabelhorn glacier reveals remains of man missing for over three decades
Discovery of massive spider's web in Greece reveals unexpected behavior
Why haven’t humans been back to the moon in over 50 years?
10 Asian Countries Perfect for Solo Female Travelers
5 Christmas movies to stream for less with this Paramount+ Black Friday deal
How to identify animal tracks, burrows and other signs of wildlife in your neighborhood
NAFFIC and Aware to Launch First China-Europe Digital Product Passport
Manual for 10 Scrumptious Specialty Mixed drinks
A24's 'Backrooms' trailer shows endless fluorescent-lit spaces and terrifying mannequins melting into the floor
Elite Execution Gaming PCs for Gamers













